Lifecore Biomedical Sets Third Quarter 2023 Earnings Conference Call for June 1, 2023 at 7:30 a.m. CT
22 Mayo 2023 - 3:49PM
Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully
integrated contract development and manufacturing organization
(“CDMO”), today announced that it will host a conference call to
discuss fiscal 2023 third quarter financial results. The live
webcast can be accessed via Lifecore’s website on the Investor
Events & Presentations page. The webcast will be available for
30 days.
Date:
Thursday, June 1, 2023
Time: 7:30 a.m. Central time
(8:30 a.m. Eastern time)
Direct Webcast link:
https://viavid.webcasts.com/starthere.jsp?ei=1612746&tp_key=4b15043655
To participate in the conference call via
telephone, dial toll-free: 1-844-826-3033 (U.S.) or 1-412-317-5185
(International). Please call the conference telephone number 5-10
minutes prior to the start time so the operator can register your
name and organization.
A replay of the call will be available through
June 8, by calling toll-free: 1-844-512-2921 (U.S.) or
1-412-317-6671 (International), and entering code 10178817.
About Lifecore Biomedical
Lifecore Biomedical, Inc. is a fully integrated
contract development and manufacturing organization (CDMO) that
offers highly differentiated capabilities in the development, fill
and finish of complex sterile injectable pharmaceutical products in
syringes and vials. As a leading manufacturer of premium,
injectable grade Hyaluronic Acid, Lifecore brings more than 40
years of expertise as a partner for global and emerging
biopharmaceutical and biotechnology companies across multiple
therapeutic categories to bring their innovations to market. For
more information about the Company, visit Lifecore’s website at
www.lifecore.com.
Contact Information:Investor
RelationsJeff Sonnek(646)
277-1263jeff.sonnek@icrinc.com
Lifecore Biomedical (NASDAQ:LFCR)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Lifecore Biomedical (NASDAQ:LFCR)
Gráfica de Acción Histórica
De May 2023 a May 2024